Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142643 |
| CAS No | NA |
| Mol.F. | C16H21ClN4O3 |
| Mol.Wt. | 352.82 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142644 |
| CAS No | NA |
| Mol.F. | C14H17ClN4O3 |
| Mol.Wt. | 324.77 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142645 |
| CAS No | NA |
| Mol.F. | C16H22N4O4 |
| Mol.Wt. | 334.38 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142646 |
| CAS No | NA |
| Mol.F. | C15H18Cl2N4O4 |
| Mol.Wt. | 389.23 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142647 |
| CAS No | NA |
| Mol.F. | C14H10ClN3O5S |
| Mol.Wt. | 367.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142648 |
| CAS No | NA |
| Mol.F. | C14H9ClN2O3 |
| Mol.Wt. | 288.69 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142649 |
| CAS No | NA |
| Mol.F. | C16H14ClN3O5S |
| Mol.Wt. | 395.81 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142650 |
| CAS No | NA |
| Mol.F. | C14H10ClN3O4S |
| Mol.Wt. | 351.76 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142651 |
| CAS No | NA |
| Mol.F. | C28H18Cl2N4O9S2 |
| Mol.Wt. | 689.49 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142652 |
| CAS No | NA |
| Mol.F. | C14H8Cl2N2O3 |
| Mol.Wt. | 323.13 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142653 |
| CAS No | NA |
| Mol.F. | C17H16ClN3O5S |
| Mol.Wt. | 409.84 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142654 |
| CAS No | NA |
| Mol.F. | C15H12ClN3O5S |
| Mol.Wt. | 381.79 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142655 |
| CAS No | NA |
| Mol.F. | C14H8Cl2N2O4S |
| Mol.Wt. | 371.19 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142656 |
| CAS No | NA |
| Mol.F. | C14H11ClN4O4S |
| Mol.Wt. | 366.78 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142657 |
| CAS No | NA |
| Mol.F. | C14H8ClN3O5 |
| Mol.Wt. | 333.68 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142658 |
| CAS No | NA |
| Mol.F. | C7H7ClN4O6S2 |
| Mol.Wt. | 342.73 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |